A study compares the benefits of fixed doses of immunotherapy compared to weight-based doses, and the Food and Drug Administration approves a targeted therapy for a rare disorder called systemic mastocytosis.

by Bradley Jones

Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

by Laurie Adami

Triplet therapy shows promise for prostate cancer that was metastatic at diagnosis, and Americans report inadequate knowledge of palliative care.

by Marci A. Landsmann

Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.

by Anna Goshua

In her new book, Cancer Support Community executive chair Kim Thiboldeaux offers advice to patients on how to steer their way through a cancer diagnosis, treatment and beyond.

by Kevin McLaughlin

A targeted therapy improves disease-free survival when given to people with certain hereditary mutations after breast cancer surgery, and the Food and Drug Administration approves a new lung cancer treatment targeting a mutated form of the KRAS protein.

by Kevin McLaughlin

A study finds that many people with solid tumors mount an antibody response following COVID-19 vaccination, and the Food and Drug Administration approves the first targeted therapy for a rare lung cancer subtype.

by Kate Yandell

Gastrointestinal oncologist and health services researcher Ryan Nipp discusses new research about how muscle quality correlates with cancer outcomes.

by Ashley P. Taylor

Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.

by Kate Yandell

The U.S. Preventive Services Task Force lowers its recommended age to begin colorectal cancer screening to 45, and a major multiple myeloma study begins in Iceland.

by Bradley Jones